Abstract
Dynamic positron emission tomography (PET) imaging of the lung using the radiotracer 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (18F-FDG) is an emerging method to assess noninvasively the metabolic activity of pulmonary inflammatory cells. Nevertheless, because of the distinct functional and structural characteristics of inflamed lung tissue standard methods of 18F-FDG analysis can be substantially limited and there is no consensus about the best method for quantification of the 18F-FDG signal for acute or chronic inflammatory lung diseases. This article gives an overview on recent advances in quantitative analysis of 18F-FDG uptake kinetics in non-neoplastic inflamed lung tissue.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 418-423 |
| Number of pages | 6 |
| Journal | Academic Radiology |
| Volume | 18 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2011 |
| Externally published | Yes |
Keywords
- Acute respiratory distress syndrome
- Chronic obstructive pulmonary disease
- Compartmental modeling
- Cystic fibrosis
- FDG
- Lung inflammation
- Positron emission tomography
- Radionuclide imaging
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging